Skip to main content

EU begins review of Bavarian Nordic's vaccine for monkeypox

EU drug regulators are reviewing the use of Bavarian Nordic's smallpox vaccine to prevent monkeypox disease. The shot is cleared in the U.S. to treat both smallpox and monkeypox.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.